RICHMOND, BRITISH COLUMBIA--(Marketwire - August 14, 2008) - BioCurex Inc. (OTCBB: BOCX) today announced that the Congress Scientific Committee has accepted its presentation to the ISOBM annual meeting. BioCurex will present results obtained with its ELISA RECAF blood test for cancer at the 2008 assembly of the International Society of Oncology and Bio-Markers (ISOBM).
